Metagenomi, Inc (MGX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Metagenomi, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Metagenomi, Inc (MGX) has returned -17.28% so far this year and -1.47% over the past 12 months.

Based on dividend-adjusted daily data since Feb 9, 2024, MGX's average daily return is -0.16%, while the average monthly return is -4.32%.

Historically, 27% of months were positive and 73% were negative. The best month was Dec 2024 with a return of +74.4%, while the worst month was Jun 2024 at -36.1%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 8 months.

On a daily basis, MGX closed higher 43% of trading days. The best single day was Dec 9, 2024 with a return of +125.4%, while the worst single day was Jun 17, 2024 at -24.1%.

Metagenomi, Inc has an annualized alpha of -42.89%, beta of 1.10, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since February 12, 2024.

• This stock participated in 217.47% of S&P 500 Index downside but only -157.14% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

MGX ranks 39 for risk / return — below 39% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Metagenomi, Inc (MGX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Metagenomi, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Metagenomi, Inc was 89.71%, occurring on Apr 3, 2025. The portfolio has not yet recovered.

The current Metagenomi, Inc drawdown is 89.06%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Metagenomi, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Metagenomi, Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.